These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 7017635)
1. [Use of pectins in the prevention and treatment of hyperlipidemia]. Bartnikowska E; Michajlik A Pol Tyg Lek; 1981 Jan; 36(1):33-6. PubMed ID: 7017635 [No Abstract] [Full Text] [Related]
2. [Therapy of hypercholesteremia with apple pectin]. Richter WO; Weisweiler P; Schwandt P Dtsch Med Wochenschr; 1981 May; 106(19):628. PubMed ID: 7215193 [No Abstract] [Full Text] [Related]
3. Controversies in primary prevention among hyperlipidemic patients. McPherson R Can J Cardiol; 1999 Apr; 15 Suppl B():16B-19B. PubMed ID: 10350678 [TBL] [Abstract][Full Text] [Related]
4. Clinical inquiries. What levels of cholesterol should be treated for primary prevention? Seaton TL; Meadows S J Fam Pract; 2002 May; 51(5):423. PubMed ID: 12019047 [No Abstract] [Full Text] [Related]
5. [Cholesterol values of an elderly person]. Viikari J Duodecim; 2002; 118(3):217-9. PubMed ID: 12233021 [No Abstract] [Full Text] [Related]
6. [Ezetimib]. Meyer Zu Schwabedissen H; Kroemer HK Dtsch Med Wochenschr; 2004 Sep; 129(39):2038-40. PubMed ID: 15386207 [No Abstract] [Full Text] [Related]
7. [Cholestrol. Metabolism. Its role in atheroslcerosis. Reduction of its levels in hypercholesterolemias]. da Silva BB; Sacramento EF Hospital (Rio J); 1969 Aug; 76(2):625-32. PubMed ID: 5307649 [No Abstract] [Full Text] [Related]
10. [Cholesterol-lowering therapy; a recommendation from the Health Council]. Comans ML Ned Tijdschr Geneeskd; 2001 Feb; 145(5):244. PubMed ID: 11219155 [No Abstract] [Full Text] [Related]
11. Overlap analysis of the West of Scotland coronary prevention study (WOSCOPS). Lim PO; Yee KM Circulation; 1999 Aug; 100(6):686. PubMed ID: 10441109 [No Abstract] [Full Text] [Related]
12. Cholesterol-lowering and vascular reactivity in relation to coronary heart disease. de Divitiis M; Rubba P Nutr Metab Cardiovasc Dis; 1999 Jun; 9(3):133-42. PubMed ID: 10464786 [TBL] [Abstract][Full Text] [Related]
13. [Dichotomy between cholesterol-lowering drugs in clinical trials and practice. Experience of the DiSCO Project (District of Serra Community Control of Chronic Degenerative Diseases)]. Volpe R; Angelico F; Ricci G; Urbinati G Cardiologia; 1997 Aug; 42(8):815-25. PubMed ID: 9312408 [No Abstract] [Full Text] [Related]
14. A need to redefine the consensus on the use of statins in coronary heart disease prevention. Fruchart JC Eur Heart J; 2000 Oct; 21(19):1572-3. PubMed ID: 10988008 [No Abstract] [Full Text] [Related]
16. Secondary prevention and treatment of hypercholesterolemia in women. Drown DJ Prog Cardiovasc Nurs; 1998; 13(3):42-3. PubMed ID: 9950023 [No Abstract] [Full Text] [Related]
17. Prevention of coronary heart disease with pravastatin. Samani NJ; de Bono DP N Engl J Med; 1996 May; 334(20):1333-4; author reply 1334-5. PubMed ID: 8609957 [No Abstract] [Full Text] [Related]
18. Treatment of high cholesterol: medications, indications, and side effects. Dent Today; 2001 Oct; 20(10):47. PubMed ID: 11665416 [No Abstract] [Full Text] [Related]
19. Eligibility for lipid-lowering drug therapy in primary prevention: how do the Adult Treatment Panel II and Adult Treatment Panel III Guidelines compare? Gotto AM; Kuller LH Circulation; 2002 Jan; 105(2):136-9. PubMed ID: 11790688 [No Abstract] [Full Text] [Related]
20. [Effectiveness and tolerability of simvastatin in patients with moderate-to-severe hypercholesterolemia. Results of a 12-month study]. Ghizzoni G; Rusconi C; Faggiano P; Sabatini T; Oneglia C; Gardini A Minerva Cardioangiol; 1993 Mar; 41(3):105-9. PubMed ID: 8510811 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]